527 related articles for article (PubMed ID: 26110508)
1. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt DP; Noble S
Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
[TBL] [Abstract][Full Text] [Related]
3. [Cervical dystonia treatment with botulin toxin].
Tomczykiewicz K
Pol Merkur Lekarski; 2016 Aug; 41(242):107-10. PubMed ID: 27591450
[TBL] [Abstract][Full Text] [Related]
4. Cervical dystonia pathophysiology and treatment options.
Velickovic M; Benabou R; Brin MF
Drugs; 2001; 61(13):1921-43. PubMed ID: 11708764
[TBL] [Abstract][Full Text] [Related]
5. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
Marciniec M; Szczepańska-Szerej A; Rejdak K
Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
10. [Cervical dystonia--diagnosis and treatment].
Skogseid IM
Tidsskr Nor Laegeforen; 2008 Oct; 128(19):2202-5. PubMed ID: 18846145
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
[TBL] [Abstract][Full Text] [Related]
12. Cervical dystonia - improving the effectiveness of botulinum toxin therapy.
Tyślerowicz M; Kiedrzyńska W; Adamkiewicz B; Jost WH; Sławek J
Neurol Neurochir Pol; 2020; 54(3):232-242. PubMed ID: 32285434
[TBL] [Abstract][Full Text] [Related]
13. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.
Albanese A; Abbruzzese G; Dressler D; Duzynski W; Khatkova S; Marti MJ; Mir P; Montecucco C; Moro E; Pinter M; Relja M; Roze E; Skogseid IM; Timerbaeva S; Tzoulis C
J Neurol; 2015 Oct; 262(10):2201-13. PubMed ID: 25877834
[TBL] [Abstract][Full Text] [Related]
14. Determinants of disability in cervical dystonia.
van den Dool J; Tijssen MA; Koelman JH; Engelbert RH; Visser B
Parkinsonism Relat Disord; 2016 Nov; 32():48-53. PubMed ID: 27553512
[TBL] [Abstract][Full Text] [Related]
15. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K
Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845
[TBL] [Abstract][Full Text] [Related]
16. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
17. [Pain and cervical dystonia].
Hamami F; Bäumer T
Schmerz; 2024 Feb; 38(1):41-47. PubMed ID: 38265520
[TBL] [Abstract][Full Text] [Related]
18. [Botulinum toxin for treatment of the focal dystonia].
Nakamura Y
Rinsho Shinkeigaku; 2017 Jul; 57(7):367-372. PubMed ID: 28652522
[TBL] [Abstract][Full Text] [Related]
19. Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses.
Bhidayasiri R
Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S20-4. PubMed ID: 21999891
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
